What is EverlyWell?
Founded in 2015 and headquartered in Austin, Texas, Everlywell has revolutionized the health and wellness industry by providing accessible at-home lab testing kits. The company empowers consumers with convenient access to a wide array of validated tests, including those for food sensitivities, fertility, sexually transmitted diseases, and thyroid function. By seamlessly connecting users to certified lab partners, Everlywell delivers digital results swiftly, enabling individuals to take proactive control of their health. The company's innovative model addresses a growing demand for personalized and convenient healthcare solutions.
How much funding has EverlyWell raised?
EverlyWell has raised a total of $304.5M across 5 funding rounds:
Angel/Seed
$2.5M
Angel/Seed
$2M
Unspecified
$50M
Series D
$175M
Private Equity
$75M
Angel/Seed (2016): $2.5M, investors not publicly disclosed
Angel/Seed (2017): $2M led by NextGen Venture Partners, Full Tilt Capital, Jack Novak, and SoGal Ventures
Unspecified (2019): $50M supported by Goodwater Capital, SoGal Ventures, Highland Capital Partners, Next Coast Ventures, and NextGen Venture Partners
Series D (2020): $175M featuring The Chernin Group, Portfolia, Morningside Ventures, Goodwater Capital, Next Coast Ventures, Highland Capital Partners, BlackRock, Lux Capital, Foresite Capital, and Greenspring Associates
Private Equity (2021): $75M backed by HealthQuest Capital
Key Investors in EverlyWell
HealthQuest Capital
HealthQuest Capital is a venture capital firm focused on investing in companies that are transforming healthcare delivery and improving patient outcomes. They typically back early-stage and growth-stage companies in areas such as digital health, medical devices, and healthcare services.
The Chernin Group
The Chernin Group (TCG) is a diversified media, technology, and consumer company that invests in and operates businesses across various sectors. They are known for their strategic investments in high-growth companies, often with a focus on media, entertainment, and technology.
Portfolia
Portfolia is an investment firm that creates funds focused on backing entrepreneurial companies, particularly those with a strong emphasis on innovation and growth potential. They aim to identify and support promising ventures across various industries.
What's next for EverlyWell?
The substantial enterprise-level backing Everlywell has garnered, particularly the recent strategic investment, positions the company for accelerated growth and market leadership. This influx of capital is anticipated to drive advancements in product development, expand testing capabilities, and enhance the user experience. Strategic capital infusion will likely support Everlywell's mission to democratize health diagnostics, making advanced testing more accessible and affordable for a broader population. Future initiatives may include expanding into new health categories, forging strategic partnerships, and further leveraging technology to deliver actionable health insights.
See full EverlyWell company page
